28 employees
GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.
2020
$49M
from 3 investors over 3 rounds
GlycoEra AG raised $49M on November 5, 2021
Investors: LimmaTech Biologics AG, 5AM Ventures and Sofinnova Partners